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Appraisal Clinical Practice Guidelines
Paediatric neuromuscular weakness
Respiratory management of children with neuromuscular weakness
Latest update: 2012. Next update: Not stated. Patient 
group: Children with respiratory muscle weakness as a 
result of neuromuscular disease or disorders of the motor 
unit. Intended audience: Healthcare practitioners who 
care for children with neuromuscular weakness, including 
doctors, nurses, and physiotherapists. Additional versions: 
Nil. Expert working group: A 13-member group 
including medical specialists, a physiotherapist, a nurse, 
and a consumer representative from the United Kingdom 
comprised the expert working group. Funded by: Not 
stated. Consultation with: A draft guideline was circulated 
to relevant medical society stakeholders, including the 
Association of Paediatric Chartered Physiotherapists and 
the British Thoracic Society Standards of Care Committee. 
It was also made available for public consultation. 
Approved by: The British Thoracic Society. Location: 
The guidelines are published as: Hull J, et al (2012) British 
Thoracic Society Guideline for respiratory management of 
children with neuromuscular weakness. Thorax 67: Suppl 
1: i1–40. They are available at: http://www.brit-thoracic.org.
uk/Guidelines/Children-with-Neuromuscular-Weakness.
aspx.
Description: This guideline is a 45-page document 
that outlines potential respiratory complications of 
neuromuscular weakness in children, then identiﬁes and 
critically appraises the research evidence underpinning 
current assessment and management approaches. It 
begins with a three-page summary of recommendations. 
The neuromuscular conditions covered by the guideline 
are detailed in the ﬁrst appendix, and the most common 
reasons for respiratory complications in each condition 
are explained. The complications covered include reduced 
pulmonary function, retention of airway secretions, 
aspiration lung disease, sleep-disordered breathing, the 
inﬂuence of scoliosis, and respiratory failure. The evidence 
underpinning tests to identify children at risk is presented, 
including recommendations for clinical assessment, 
spirometry, tests of respiratory muscle strength, and peak 
ﬂow. Recommendations are made on the use of a variety 
of chest physiotherapy techniques for airway clearance and 
respiratory muscle training, in addition to presentation of 
evidence for several forms of assisted ventilation. Other 
issues discussed include respiratory preparation for surgical 
procedures, the impact of scoliosis, other problems that 
impact on respiratory health, the transition to adult care, 
quality of life, and palliative care.
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Cardiovascular disease risk
Management of absolute cardiovascular disease risk
Latest update: 2012. Next update: 2016/17. Patient group: 
Adults aged over 45 years who have no previous history of 
cardiovascular disease (CVD). Intended audience: General 
practitioners and other primary health care professionals. 
Additional versions: Several resources are available on the 
Stroke Foundation website including a quick reference guide, 
an online risk calculator, links to videos, and a consumer 
booklet on management of their heart/stroke risk. Expert 
working group: A 12-member group was formed including 
endocrinologists, cardiologists, nephrologists, general 
practitioners, geriatricians, a consumer, and pharmaceutical 
beneﬁts representative from Australia. In addition, a 
17-member advisory committee contributed. Funded by: 
The Stroke Foundation of Australia. Consultation with: 
A 22-member multidisciplinary corresponding group 
including allied health assisted with the development of 
the guidelines. Approved by: Diabetes Australia, Heart 
Foundation, Stroke Foundation, Kidney Health Australia, the 
National Health & Medical Research Council and the Royal 
Australian College of General Practitioners. Location: The 
guidelines are available at: http://strokefoundation.com.au/
health-professionals/clinical-guidelines/guidelines-for-the-
assessment-and-management-of-absolute-cvd-risk/
Description: This guideline is a 124-page document that 
encompasses the assessment, treatment, and monitoring of 
multiple CVD risk factors in adults. The guidelines provide 
evidence for the calculation of absolute CVD risk, which 
is the likelihood of a person experiencing a cardiovascular 
event within the next ﬁve years. The guidelines commence 
with algorithms and tables that provide a summary of the 
recommended risk assessment pathway, interventions, 
targets, and follow up. Best evidence for how to measure 
risk factors and speciﬁc cut-off levels is presented for both 
the general adult and speciﬁc populations such as those 
aged over 74 years, Aboriginal and Torres Strait Islander 
peoples, and those with speciﬁc medical conditions. 
Evidence-based recommendations for treatments to reduce 
cardiovascular risk are then detailed, including modiﬁcation 
of lifestyle factors (eg, nutrition, physical activity) and 
pharmacotherapy. These have again been collated for several 
populations including those requiring special consideration. 
Finally, detailed information is provided outlining barriers 
and practical enablers to facilitate implementation of these 
recommendations.
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